Even for formulations without B12, avoiding direct light exposure is good practice
Many of my patients have come to me with questions about this new class of medications that are being used for both diabetes and weight loss
Pompella A, Visvikis A, Paolicchi A, De Tata V, Casini AF: The changing faces of glutathione, a cellular protagonist
Details As the publication indicates, previous studies have shown that "people receiving a standard weekly injection of the drug "Wegovy", which contains the active ingredient semaglutide, typically lose about 15% of their body weight within a year in combination with exercise and a healthy diet." The drug works by mimicking the action of the hormone glucagon-like peptide-1, or GLP1, which causes delayed gastric emptying and affects the brain, reducing appetite
Continuing healthy eating and exercise can counteract some of this, but many people find they do better staying on the medication long-term to help fight those signals
From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research